PTX.AX
Prescient Therapeutics Ltd
Price:
0.05
AUD
Volume:
577,057
Australia | Biotechnology
PTX.AX Gross Margin
As of 2025-05-21, the Gross Margin of Prescient Therapeutics Ltd (PTX.AX) is 7775.2%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
PTX.AX Gross Margin - Historical Value
| Date | Value |
|---|---|
| 2024-06-30 | 7775.2% |
| 2023-06-30 | - |
| 2022-06-30 | - |
| 2021-06-30 | - |
| 2020-06-30 | - |
| 2019-06-30 | - |
| 2018-06-30 | - |
| 2017-06-30 | - |
| 2016-06-30 | - |
| 2015-06-30 | - |
PTX.AX Gross Margin - Peers Comparison